MedTrace Logo

Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities

NCT02621476 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63012

Last updated 2023-08-08

Study results available
· View outcomes & findings →

Summary

The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente Hawaii.

Conditions

Interventions

BEHAVIORAL

Standardized intervention

Standardized intervention to encourage mail order use and provide easily accessible information on how to access the service

BEHAVIORAL

Usual care

Usual care

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Harvard Pilgrim Health Care

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Julie A Schmittdiel · Research Scientist

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2018-05-30
Completion
2022-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02621476 on ClinicalTrials.gov